Concepts (109)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Huntington Disease | 5 | 2021 | 124 | 0.580 |
Why?
|
| Myotonic Dystrophy | 1 | 2013 | 74 | 0.370 |
Why?
|
| tau Proteins | 3 | 2023 | 258 | 0.360 |
Why?
|
| Huntingtin Protein | 4 | 2021 | 62 | 0.350 |
Why?
|
| RNA-Binding Proteins | 2 | 2013 | 541 | 0.340 |
Why?
|
| Tauopathies | 2 | 2023 | 75 | 0.300 |
Why?
|
| Nerve Tissue Proteins | 4 | 2012 | 1091 | 0.200 |
Why?
|
| Drosophila Proteins | 3 | 2021 | 786 | 0.180 |
Why?
|
| Electrical Synapses | 1 | 2021 | 15 | 0.170 |
Why?
|
| Protein Kinase C beta | 1 | 2019 | 17 | 0.150 |
Why?
|
| Alzheimer Disease | 4 | 2023 | 876 | 0.150 |
Why?
|
| Drosophila | 7 | 2023 | 794 | 0.150 |
Why?
|
| Neuroglia | 1 | 2021 | 223 | 0.150 |
Why?
|
| Synaptic Transmission | 1 | 2021 | 323 | 0.150 |
Why?
|
| Protein Kinases | 2 | 2019 | 319 | 0.140 |
Why?
|
| Amyloid beta-Protein Precursor | 1 | 2019 | 116 | 0.140 |
Why?
|
| Amyloidosis | 1 | 2019 | 69 | 0.140 |
Why?
|
| Behavior, Animal | 2 | 2021 | 486 | 0.140 |
Why?
|
| Nuclear Proteins | 3 | 2010 | 1229 | 0.130 |
Why?
|
| Amyloid beta-Peptides | 1 | 2019 | 235 | 0.130 |
Why?
|
| Phosphotransferases (Alcohol Group Acceptor) | 1 | 2017 | 72 | 0.130 |
Why?
|
| High-Throughput Screening Assays | 1 | 2018 | 116 | 0.130 |
Why?
|
| Disease Models, Animal | 9 | 2021 | 4664 | 0.130 |
Why?
|
| Tripartite Motif-Containing Protein 28 | 1 | 2016 | 16 | 0.130 |
Why?
|
| Brain | 4 | 2023 | 3194 | 0.120 |
Why?
|
| RNA Interference | 2 | 2019 | 495 | 0.120 |
Why?
|
| alpha-Synuclein | 1 | 2016 | 141 | 0.110 |
Why?
|
| Enzyme Inhibitors | 1 | 2017 | 568 | 0.110 |
Why?
|
| Neurodegenerative Diseases | 2 | 2007 | 289 | 0.100 |
Why?
|
| Cell Nucleus | 1 | 2016 | 569 | 0.100 |
Why?
|
| Myoblasts | 1 | 2013 | 34 | 0.100 |
Why?
|
| Repressor Proteins | 1 | 2016 | 774 | 0.090 |
Why?
|
| ras Proteins | 1 | 2012 | 147 | 0.090 |
Why?
|
| Animals | 12 | 2023 | 33924 | 0.080 |
Why?
|
| Matrix Metalloproteinases | 1 | 2010 | 62 | 0.080 |
Why?
|
| Drosophila melanogaster | 4 | 2021 | 850 | 0.080 |
Why?
|
| Mice | 7 | 2023 | 18213 | 0.070 |
Why?
|
| Heterogeneous-Nuclear Ribonucleoprotein Group A-B | 1 | 2007 | 11 | 0.070 |
Why?
|
| Trinucleotide Repeat Expansion | 1 | 2007 | 82 | 0.060 |
Why?
|
| Fragile X Syndrome | 1 | 2007 | 148 | 0.060 |
Why?
|
| Ubiquitin | 1 | 2006 | 132 | 0.060 |
Why?
|
| Cell Line | 2 | 2021 | 2578 | 0.050 |
Why?
|
| Mice, Transgenic | 2 | 2021 | 2346 | 0.050 |
Why?
|
| Gene Expression Regulation | 1 | 2013 | 2356 | 0.050 |
Why?
|
| Cells, Cultured | 3 | 2017 | 2905 | 0.050 |
Why?
|
| Phosphorylation | 2 | 2019 | 1577 | 0.050 |
Why?
|
| Fibroblasts | 2 | 2018 | 857 | 0.050 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2006 | 361 | 0.050 |
Why?
|
| RNA, Small Interfering | 2 | 2019 | 667 | 0.050 |
Why?
|
| Ubiquitin-Specific Peptidase 7 | 1 | 2023 | 18 | 0.050 |
Why?
|
| Transcriptome | 2 | 2021 | 1130 | 0.050 |
Why?
|
| Neurons | 4 | 2017 | 2018 | 0.050 |
Why?
|
| Humans | 11 | 2023 | 130447 | 0.050 |
Why?
|
| Corpus Striatum | 2 | 2012 | 93 | 0.040 |
Why?
|
| Locomotion | 1 | 2021 | 56 | 0.040 |
Why?
|
| alpha 1-Antitrypsin | 1 | 2021 | 81 | 0.040 |
Why?
|
| Cell Adhesion Molecules, Neuronal | 1 | 2021 | 82 | 0.040 |
Why?
|
| Cell Line, Tumor | 2 | 2019 | 3720 | 0.040 |
Why?
|
| NIH 3T3 Cells | 1 | 2019 | 91 | 0.040 |
Why?
|
| Plaque, Amyloid | 1 | 2019 | 68 | 0.040 |
Why?
|
| Models, Biological | 2 | 2017 | 1390 | 0.040 |
Why?
|
| Gene Regulatory Networks | 1 | 2021 | 384 | 0.040 |
Why?
|
| Mutation | 3 | 2021 | 6132 | 0.030 |
Why?
|
| Protein Aggregation, Pathological | 1 | 2017 | 39 | 0.030 |
Why?
|
| Ataxins | 2 | 2007 | 109 | 0.030 |
Why?
|
| Proteolysis | 1 | 2017 | 197 | 0.030 |
Why?
|
| Supranuclear Palsy, Progressive | 1 | 2016 | 29 | 0.030 |
Why?
|
| Gene Knockdown Techniques | 1 | 2017 | 382 | 0.030 |
Why?
|
| Ataxin-1 | 2 | 2007 | 161 | 0.030 |
Why?
|
| Immunoblotting | 1 | 2016 | 293 | 0.030 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2016 | 413 | 0.030 |
Why?
|
| Induced Pluripotent Stem Cells | 1 | 2018 | 245 | 0.030 |
Why?
|
| Fear | 1 | 2016 | 193 | 0.030 |
Why?
|
| Peptides | 2 | 2010 | 708 | 0.030 |
Why?
|
| Autophagy | 1 | 2017 | 421 | 0.030 |
Why?
|
| Genetic Therapy | 1 | 2019 | 718 | 0.030 |
Why?
|
| Case-Control Studies | 1 | 2021 | 3389 | 0.030 |
Why?
|
| Farnesyltranstransferase | 1 | 2012 | 8 | 0.020 |
Why?
|
| Genetic Testing | 1 | 2019 | 1100 | 0.020 |
Why?
|
| Triazoles | 1 | 2012 | 138 | 0.020 |
Why?
|
| Metabolic Networks and Pathways | 1 | 2012 | 194 | 0.020 |
Why?
|
| Gene Expression Profiling | 1 | 2018 | 1829 | 0.020 |
Why?
|
| Mice, Neurologic Mutants | 1 | 2010 | 74 | 0.020 |
Why?
|
| Cell Line, Transformed | 1 | 2010 | 160 | 0.020 |
Why?
|
| HEK293 Cells | 1 | 2012 | 811 | 0.020 |
Why?
|
| Cell Death | 1 | 2010 | 233 | 0.020 |
Why?
|
| Caspases | 1 | 2010 | 156 | 0.020 |
Why?
|
| Parkinson Disease | 1 | 2016 | 722 | 0.020 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2010 | 243 | 0.020 |
Why?
|
| Pyrimidines | 1 | 2012 | 452 | 0.020 |
Why?
|
| Transfection | 1 | 2010 | 962 | 0.020 |
Why?
|
| CELF1 Protein | 1 | 2007 | 34 | 0.020 |
Why?
|
| Microscopy, Electron, Scanning | 1 | 2007 | 117 | 0.020 |
Why?
|
| Mitochondria | 1 | 2012 | 764 | 0.020 |
Why?
|
| Immunoprecipitation | 1 | 2007 | 192 | 0.020 |
Why?
|
| Intranuclear Inclusion Bodies | 1 | 2006 | 11 | 0.020 |
Why?
|
| Animals, Genetically Modified | 1 | 2007 | 328 | 0.020 |
Why?
|
| Photoreceptor Cells, Invertebrate | 1 | 2006 | 58 | 0.010 |
Why?
|
| Eye | 1 | 2007 | 220 | 0.010 |
Why?
|
| Genome, Human | 1 | 2012 | 1322 | 0.010 |
Why?
|
| Protein Folding | 1 | 2006 | 215 | 0.010 |
Why?
|
| Molecular Chaperones | 1 | 2006 | 172 | 0.010 |
Why?
|
| Transgenes | 1 | 2006 | 321 | 0.010 |
Why?
|
| Spinocerebellar Ataxias | 1 | 2006 | 152 | 0.010 |
Why?
|
| Protein Conformation | 1 | 2006 | 729 | 0.010 |
Why?
|
| Male | 2 | 2021 | 64550 | 0.010 |
Why?
|
| Female | 2 | 2021 | 70337 | 0.010 |
Why?
|
| Adult | 1 | 2023 | 31131 | 0.010 |
Why?
|
| Signal Transduction | 1 | 2012 | 4675 | 0.010 |
Why?
|